Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BWAYNYSE:ELMDNASDAQ:GUTSNASDAQ:SURG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBWAYBrainsWay$8.85-2.5%$10.11$4.61▼$11.79$166.62M1.1773,648 shs59,199 shsELMDElectromed$22.39-5.0%$27.97$13.74▼$35.56$191.59M0.5967,484 shs98,533 shsGUTSFractyl Health$1.12-1.8%$1.45$1.07▼$7.89$54.79M0.3290,283 shs211,806 shsSURGSurgePays$2.33-0.9%$1.49$1.05▼$4.38$47.56M0.57626,793 shs491,115 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBWAYBrainsWay0.00%-4.84%-3.49%-9.14%+57.47%ELMDElectromed0.00%-4.07%-9.39%-27.04%+45.11%GUTSFractyl Health0.00%-9.68%-28.66%-49.09%-84.76%SURGSurgePays0.00%+30.17%+82.03%+29.44%-44.12%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBWAYBrainsWay2.8547 of 5 stars3.53.00.00.02.60.81.9ELMDElectromed0.9104 of 5 stars2.00.00.00.02.72.50.0GUTSFractyl Health1.2992 of 5 stars3.52.00.00.00.61.70.0SURGSurgePays2.8228 of 5 stars3.55.00.00.02.11.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBWAYBrainsWay 3.00Buy$13.1748.78% UpsideELMDElectromed 4.00Strong Buy$38.0069.72% UpsideGUTSFractyl Health 3.00Buy$10.00792.86% UpsideSURGSurgePays 3.00Buy$8.50264.81% UpsideCurrent Analyst Ratings BreakdownLatest SURG, GUTS, BWAY, and ELMD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/12/2025BWAYBrainsWayHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$16.00 ➝ $16.002/20/2025ELMDElectromedB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$38.002/19/2025ELMDElectromedB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy2/3/2025GUTSFractyl HealthMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$18.00 ➝ $10.00(Data available from 4/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBWAYBrainsWay$41.02M4.06N/AN/A$2.50 per share3.54ELMDElectromed$59.63M3.21$0.54 per share41.36$5.10 per share4.39GUTSFractyl Health$93K589.14N/AN/AN/A∞SURGSurgePays$60.88M0.78$2.14 per share1.09$1.68 per share1.39Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBWAYBrainsWay-$4.20M$0.1788.5155.31N/A3.88%3.52%2.26%5/6/2025 (Estimated)ELMDElectromed$5.15M$0.7529.85∞N/A11.34%15.71%13.37%N/AGUTSFractyl Health-$77.09M-$1.53N/AN/AN/A-64,849.48%N/A-57.21%4/7/2025 (Estimated)SURGSurgePays$20.62M-$2.34N/AN/AN/A-27.39%-55.63%-43.61%5/12/2025 (Estimated)Latest SURG, GUTS, BWAY, and ELMD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/25/2025Q4 2024SURGSurgePays-$0.27-$0.93-$0.66-$1.02$8.22 million$9.59 million3/3/2025Q4 2024GUTSFractyl Health-$0.44-$0.52-$0.08-$0.52N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBWAYBrainsWayN/AN/AN/AN/AN/AELMDElectromedN/AN/AN/AN/AN/AGUTSFractyl HealthN/AN/AN/AN/AN/ASURGSurgePaysN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBWAYBrainsWayN/A4.524.23ELMDElectromedN/A5.104.74GUTSFractyl Health0.605.585.57SURGSurgePays0.086.244.70Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBWAYBrainsWay30.11%ELMDElectromed40.82%GUTSFractyl HealthN/ASURGSurgePays6.94%Insider OwnershipCompanyInsider OwnershipBWAYBrainsWay19.00%ELMDElectromed14.00%GUTSFractyl HealthN/ASURGSurgePays29.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBWAYBrainsWay12018.83 million15.24 millionNot OptionableELMDElectromed1608.56 million7.36 millionOptionableGUTSFractyl Health10248.92 millionN/AN/ASURGSurgePays4020.41 million14.23 millionOptionableSURG, GUTS, BWAY, and ELMD HeadlinesRecent News About These CompaniesSurgePays to Participate in Water Tower Research Fireside Chat on Tuesday, April 8, 2025April 3 at 1:31 PM | prnewswire.comCritical Contrast: BCE (NYSE:BCE) and SurgePays (NASDAQ:SURG)March 30, 2025 | americanbankingnews.comResearch Analysts Set Expectations for SurgePays Q1 EarningsMarch 30, 2025 | americanbankingnews.comSidoti Csr Weighs in on SurgePays' Q4 Earnings (NASDAQ:SURG)March 29, 2025 | americanbankingnews.comPenny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to SellMarch 27, 2025 | msn.comSurgePays Full Year 2024 Earnings: Revenues Beat Expectations, EPS LagsMarch 27, 2025 | finance.yahoo.comSurgePays And 2 Other Promising Penny Stocks To WatchMarch 27, 2025 | finance.yahoo.comPenny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell March 27, 2025 | marketbeat.comSurgePays, Inc. (NASDAQ:SURG) Q4 2024 Earnings Call TranscriptMarch 27, 2025 | insidermonkey.comShares Of This Software Company Found Serious Mid-Week SuccessMarch 27, 2025 | msn.comSurgePays sees FY25 revenue $200M, consensus $95.11MMarch 27, 2025 | markets.businessinsider.comQ4 2024 Surgepays Inc Earnings CallMarch 27, 2025 | finance.yahoo.comSurgePays guides $200M revenue in the coming 12 months, stock soarsMarch 27, 2025 | msn.comSurgePays Stock Surges As Strong Guidance Overshadows FY24 Underperformance: Retail Anticipates Multi-Day RunMarch 27, 2025 | msn.comSurgePays Sees Unusually Large Options Volume (NASDAQ:SURG)March 27, 2025 | americanbankingnews.comTariff Uncertainty Drives Quiet Premarket Action for Equity FuturesMarch 26, 2025 | msn.comStocks to Watch: GameStop, SurgePays, TheratechnologiesMarch 26, 2025 | marketwatch.comSurgePays Shares Soar on Revenue OutlookMarch 26, 2025 | marketwatch.comSurgePays, Inc. (SURG) Q4 2024 Earnings Call TranscriptMarch 25, 2025 | seekingalpha.comSurgePays, Inc. (SURG) Reports Q4 Loss, Tops Revenue EstimatesMarch 25, 2025 | zacks.comSurgePays Reports 2024 Financial Results and Issues Revenue Guidance of Over $200 Million in Next 12 MonthsMarch 25, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesCybersecurity Stocks Surge as $32B Deal Reshapes the IndustryBy Gabriel Osorio-Mazilli | March 21, 2025View Cybersecurity Stocks Surge as $32B Deal Reshapes the IndustryIntel Stock Surges on New CEO – The Real Story Runs DeeperBy Gabriel Osorio-Mazilli | March 13, 2025View Intel Stock Surges on New CEO – The Real Story Runs DeeperSpace Stocks Bottoming: Which Are Positioned Best for a Bounce?By Ryan Hasson | March 25, 2025View Space Stocks Bottoming: Which Are Positioned Best for a Bounce?Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell By Thomas Hughes | March 27, 2025View Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell Could Palantir’s R1 Deal Be the Catalyst for a Stock Surge?By Chris Markoch | March 21, 2025View Could Palantir’s R1 Deal Be the Catalyst for a Stock Surge?SURG, GUTS, BWAY, and ELMD Company DescriptionsBrainsWay NASDAQ:BWAY$8.85 -0.23 (-2.53%) Closing price 04/4/2025 04:00 PM EasternExtended Trading$8.86 +0.01 (+0.11%) As of 04/4/2025 04:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.Electromed NYSE:ELMD$22.39 -1.19 (-5.05%) Closing price 04/4/2025 04:00 PM EasternExtended Trading$21.37 -1.02 (-4.55%) As of 04/4/2025 04:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.Fractyl Health NASDAQ:GUTS$1.12 -0.02 (-1.75%) Closing price 04/4/2025 04:00 PM EasternExtended Trading$1.18 +0.05 (+4.91%) As of 04/4/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.SurgePays NASDAQ:SURG$2.33 -0.02 (-0.85%) Closing price 04/4/2025 04:00 PM EasternExtended Trading$2.26 -0.06 (-2.79%) As of 04/4/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SurgePays, Inc., together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities. SurgePays, Inc. is headquartered in Bartlett, Tennessee. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 03/31 - 04/04 Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential? Conagra Stock Could Thrive as Tariffs Hit Other Sectors Archer Aviation’s Africa Deal Could Boost ACHR Stock The Ecosystem Edge: Joby's Competitive Advantage Advance Auto Parts Stock: A Classic Rebound Play in the Making Intel’s Big Bet on 18A: Will Lip-Bu Tan’s Vision Pay Off? Lamb Weston Stock Rises, Earnings Provide Calm Amidst Chaos Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
